Disclosure: This is an affiliate site. We may earn compensation from partners. Full disclosure | Medical disclaimer
Novo Nordisk shipping Wegovy and Ozempic direct to cash-paying patients
Also searched as: NovoCare, Novo Nordisk direct
$149/mo
Brand-name
Cash-pay
August 30, 2026
NovoCare Pharmacy is Novo Nordisk's direct-to-patient channel, the semaglutide counterpart to Lilly's LillyDirect. Novo launched it in March 2025 to bring every dose strength of Wegovy to cash-paying patients at $499 a month with home delivery, well under the roughly $1,350 list price.
Pricing has since become dose-tiered and considerably cheaper at the low end. Novo's published self-pay guide lists $149 per month for the 1.5 mg and 4 mg strengths, and $299 per month for 9 mg and 25 mg — figures that reflect the oral Wegovy tablets as well as the injection.
Like LillyDirect, this is a pharmacy rather than a program. It solves authenticity and price; it does not provide the clinician, the coaching or the accountability.
FDA-approved brand-name Novo Nordisk products only. No compounded semaglutide is sold or dispensed through NovoCare Pharmacy.
None provided. You need a prescription from your own healthcare provider, who sends it to NovoCare Pharmacy. Novo confirms receipt by text.
Per the FDA label for chronic weight management: adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition. Self-pay pricing requires that you are paying cash rather than billing insurance.
None from Novo Nordisk. Your own prescriber manages dosing, titration and monitoring; NovoCare Pharmacy only dispenses.
Not applicable. Any monitoring is arranged by your prescriber.
NovoCare Pharmacy, operated as Novo Nordisk's own direct-to-patient dispensing channel.
Free home delivery on all dose strengths. Semaglutide requires refrigerated cold-chain shipping at 2-8°C (36-46°F) — see our storage and shipping guide before your first delivery.
Pharmacy support and shipment scheduling through NovoCare. Novo also runs a separate savings offer program for commercially insured patients.
None. NovoCare Pharmacy charges per fill, with no subscription or platform fee.
The published self-pay price for your dose strength, which changes as you titrate. Note the 4 mg promotional price expires August 31, 2026.
Nothing to cancel — you are buying fills, not subscribing. Stop reordering at any time.
Dispensed prescription medication generally cannot be returned. Contact NovoCare Pharmacy for damaged, delayed or temperature-compromised shipments.
Self-pay pricing is for cash-paying patients. Separately, Novo runs a savings offer that can bring eligible commercially insured patients to as little as $25 a month. From July 1, 2026, the Medicare GLP-1 Bridge program covers Wegovy in both injection and tablet form at $50 a month for eligible beneficiaries.
Yes. FDA-approved prescription medication for a diagnosed condition is a qualified HSA and FSA expense.
Pricing in this review reflects what NovoCare Pharmacy and named third-party sources published as of August 30, 2026. Telehealth pricing changes frequently — confirm the current figure at checkout before you buy.
Cash-paying patients who already have a semaglutide prescription from their own doctor and want the lowest verified price on genuine Wegovy with free delivery.
NovoCare Pharmacy cannot start you on treatment. If you do not already have a prescriber willing to manage GLP-1 therapy, you need a telehealth platform or a primary care physician first, and then you can route the prescription here.
Novo's published self-pay guide lists $149 per month for the 1.5 mg and 4 mg strengths and $299 per month for 9 mg and 25 mg, with the injectable self-pay price listed at $399 per month. The 4 mg offer runs to August 31, 2026, after which that strength is $199 per month. The program originally launched in March 2025 at a flat $499 per month for all doses.
Yes. NovoCare Pharmacy only dispenses — it does not employ prescribers. Your healthcare provider sends the prescription to NovoCare, and you get a confirmation text.
Yes. Novo advertises free home delivery straight to your door on all dose strengths. Because semaglutide requires refrigeration at 2-8°C, deliveries arrive in validated cold-chain packaging.
The self-pay prices are for cash-paying patients. Separately, Novo runs a savings offer that can bring eligible commercially insured patients to as little as $25 a month. From July 1, 2026, eligible Medicare beneficiaries can get Wegovy for $50 a month through the Medicare GLP-1 Bridge program.
No. NovoCare dispenses only FDA-approved Novo Nordisk products. Novo Nordisk has been publicly opposed to compounded copies of its semaglutide products.
No. Zepbound is tirzepatide, made by Eli Lilly. NovoCare carries only Novo Nordisk medications. For tirzepatide, use LillyDirect.
Every pricing and policy claim on this page traces back to one of these sources, checked on August 30, 2026.
Self-pay price; the 4 mg offer runs to August 31, 2026, then $199/mo
Self-pay price for the higher oral strengths
Published self-pay price for the injectable pen
The original March 2025 flat rate, now superseded by dose-tiered pricing
Via the Wegovy savings offer for eligible commercially insured patients
Verified August 30, 2026. Prices change often — confirm before purchase.
Share your experience with NovoCare Pharmacy to help others make informed decisions.
This review is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GLP-1 medications are prescription drugs with serious potential side effects and are not appropriate for everyone. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. Individual results vary. This page contains affiliate links, and we may earn compensation if you use them.
Date reviewed: August 30, 2026